Is Heartbeam Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: BEAT) stock is to Strong Buy BEAT stock.
Out of 2 analysts, 1 (50%) are recommending BEAT as a Strong Buy, 1 (50%) are recommending BEAT as a Buy, 0 (0%) are recommending BEAT as a Hold, 0 (0%) are recommending BEAT as a Sell, and 0 (0%) are recommending BEAT as a Strong Sell.
What is BEAT's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: BEAT) forecast ROE is N/A, which is considered weak.
What is BEAT's Price Target?
According to 2 Wall Street analysts that have issued a 1 year BEAT price target, the average BEAT price target is $6.78, with the highest BEAT stock price forecast at $8.00 and the lowest BEAT stock price forecast at $5.55.
On average, Wall Street analysts predict that Heartbeam's share price could reach $6.78 by Aug 24, 2024. The average Heartbeam stock price prediction forecasts a potential upside of 185.86% from the current BEAT share price of $2.37.
What is BEAT's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: BEAT) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.